Business / Finance

RSS

Adolescent and young cancer cost barriers: an interview with Anne Kirchhoff

According to the National Cancer Institute, almost 70,000 people ages 15-39 are diagnosed with cancer each year in the United States. Cancers in this adolescent and young adult (AYA) population differ quite a bit across this age span.

3 Oct 2012

Washington Post buys major stake in Celtic Healthcare Inc.; Tenet plans buybacks

Post Co. said Monday it would buy a majority stake in Celtic Healthcare Inc., a closely held provider of hospice and home health care in Pennsylvania and Maryland. Terms of the deal weren't disclosed, although one analyst, Sheryl Skolnick of CRT Capital Group, said average valuations suggests the deal could have been worth at least $50 million. That is a drop in the bucket for Post Co., which has a market capitalization of $2.7 billion.

3 Oct 2012

Humble Surgical Hospital acquires Mazor Robotics’ Renaissance system

Mazor Robotics Ltd., a developer of innovative surgical robots and complementary products, today announced that Humble Surgical Hospital in Humble, Texas acquired its Renaissance system.

3 Oct 2012

Alimera completes $40 million convertible preferred stock sale

Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it has completed the sale of $40 million of Series A Convertible Preferred Stock and warrants to purchase Series A Preferred to a group of institutional investors, including both existing and new investors, in a private placement.

3 Oct 2012

ProStrakan acquires US commercial rights to Fareston for treatment of metastatic breast cancer

ProStrakan Group plc announces today that it has acquired exclusive US commercial rights to Fareston (toremifene citrate) for the treatment of metastatic breast cancer in postmenopausal women.

1 Oct 2012

National Health Investors acquires senior living campus in Loma Linda, California

National Health Investors, Inc. announced today the $12 million acquisition of a 181-unit senior living campus in Loma Linda, California funded from available cash and from borrowings on NHI's revolving credit facility.

1 Oct 2012

Hackensack University Medical Center announces joint venture with community physicians and USPI

Hackensack University Medical Center has announced a joint venture partnership with community physicians and United Surgical Partners International (USPI) in the acquisition and operation of two ambulatory surgery centers (ASCs) in Bergen County: Hackensack Endoscopy Center (HEC) and Endoscopy Center of Bergen County (ECBC).

29 Sep 2012

ConvaTec acquires 180 Medical

ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today it has completed the acquisition of 180 Medical Holdings, Inc.

29 Sep 2012

Shengtai sales revenue increases 4.26% to $179,029,127 for fiscal year 2012

Shengtai Pharmaceutical, Inc., a manufacturer and distributor in China of glucose and starch as pharmaceutical raw materials and other starch and glucose products, today reported financial results for the twelve months ended June 30, 2012.

29 Sep 2012

BioTime forms new wholly owned subsidiary

BioTime, Inc., an Alameda-based company engaged in research and development of innovative new products in the field of regenerative medicine utilizing stem cells and related technology, announced today that it has formed a new wholly owned subsidiary, BioTime Acquisition Corporation, to pursue opportunities and acquire assets and businesses in the fields of stem cells and regenerative medicine.

29 Sep 2012

TPG acquires Par Pharmaceutical Companies

Par Pharmaceutical Companies, Inc., and TPG today announced the completion of Par's acquisition by certain affiliates of TPG.

28 Sep 2012

Tianyin Pharmaceutical sales decrease 26.9% to $69.6 million for fiscal year 2012

Tianyin Pharmaceutical Inc., a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the fiscal year 2012.

28 Sep 2012

Lessons on the journey to commercialisation

One of the Asia Pacific region’s best known biotech leaders, Dr Greg Collier, says successful commercialisation of a new drug or therapy takes, “discipline, a strong set of nerves and a stroke of luck.”

28 Sep 2012

Physicians Endoscopy announces acquisition of minority interest in DHA

Physicians Endoscopy, LLC (PE), the leading GI ASC development and management company in the ASC industry, is pleased to announce the acquisition of a minority interest in the Digestive Health Associates Endoscopy Center, LLC (DHA) located in Stoneham, MA.

28 Sep 2012

Teva concludes Asset Transfer Agreement with NeuroSearch

Teva Pharmaceutical Industries Ltd announced today that it has concluded an Asset Transfer Agreement with NeuroSearch A/S of Denmark to purchase all rights, assets and obligations relating to Huntexil (pridopidine / ACR16), a drug candidate being developed for the symptomatic treatment of hand movement, balance and gait disturbances in Huntington disease (HD).

28 Sep 2012

Medtronic to acquire Kanghui

Medtronic, Inc. and China Kanghui Holdings announced today that they have entered into a merger agreement whereby Medtronic will acquire Kanghui.

From Medtronic 28 Sep 2012

Prime Healthcare Services purchases Dallas Medical Center

Prime Healthcare Services announced today that it has purchased Dallas Medical Center, located in Dallas, Texas.

27 Sep 2012

GP Strategies completes acquisition of Rovsing Dynamics

Global performance improvement solutions provider GP Strategies Corporation announced that it has completed its acquisition of operating assets of Rovsing Dynamics, a provider of vibration condition monitoring hardware and software.

27 Sep 2012

Landec first quarter revenues increase 39% to $102.1 million

Landec Corporation today reported results for the first quarter of fiscal year 2013 ended August 26, 2012. Revenues increased 39% to $102.1 million compared to revenues of $73.3 million for the first quarter a year ago. Net income increased 40% to $2.5 million or $0.10 per share compared to $1.8 million or $0.07 per share for the first quarter of last year.

27 Sep 2012

Retail Benefits acquires My HSA Rewards

Retail Benefits today announced the acquisition of My HSA Rewards, an innovative program that allows employees to use cash back from shopping to reduce healthcare costs.

26 Sep 2012